Iradimed (IRMD) Gross Profit (2013 - 2026)

Iradimed (IRMD) has 14 years of Gross Profit data on file, last reported at $16.8 million in Q1 2026.

• Gross Profit for Q1 2026 came in at $16.8 million, up 13.28% year-over-year; the trailing twelve-month figure through Mar 2026 was $66.3 million (up 14.69% YoY), and the FY2025 annual result was $64.3 million, up 14.15% from the prior year.
• Gross Profit declined to $16.8 million in Q1 2026 per IRMD's latest filing, from $17.0 million in the prior quarter.
• Over five years, Gross Profit peaked at $17.0 million in Q4 2025 and troughed at $9.4 million in Q1 2022.
• A 5-year average of $13.5 million and a median of $13.4 million in 2023 frame the typical range for Gross Profit.
• The sharpest annual moves came in 2022 and 2024: Gross Profit surged 38.29% in 2022, then increased 10.05% in 2024.
• A 5-year view of Gross Profit shows it stood at $11.2 million in 2022, then increased by 19.54% to $13.4 million in 2023, then rose by 10.05% to $14.8 million in 2024, then rose by 15.38% to $17.0 million in 2025, then dropped by 1.28% to $16.8 million in 2026.
• Business Quant data shows IRMD's Gross Profit at $16.8 million in Q1 2026, $17.0 million in Q4 2025, and $16.5 million in Q3 2025.